FROM TRADITIONAL MEDICINE TO MODERN THERAPEUTICS:THE CARDIOMETABOLIC POTENTIAL OF PURSLANE
Portulaca oleracea L., commonly known as purslane, is an edible and medicinal plant belonging to the family Portulacaceae. Owing to its nutritional richness and diverse pharmacological properties, it has attracted considerable scientific interest as a potential source of bioactive compounds with relevance to human health. The plant contains several biologically active constituents, including alpha-linolenic acid, flavonoids, alkaloids, polysaccharides, phenolic compounds and essential nutrients. Experimental investigations and emerging clinical evidence have demonstrated its potential antioxidant, anti-inflammatory, hypoglycemic, hypolipidemic and cardioprotective activities. These biological effects may be associated with the modulation of glucose homeostasis, lipid metabolism, oxidative stress, inflammatory responses, blood pressure regulation and endothelial function. Consequently, increasing attention has been directed towards its potential role in the prevention and management of cardiometabolic disorders, including metabolic syndrome, type 2 diabetes mellitus (T2DM), non-alcoholic fatty liver disease (NAFLD) and associated cardiovascular complications. However, the translation of these promising findings into clinical applications remains challenging due to variations in plant preparation, extraction methods, dosage, treatment duration and study designs, as well as inconsistencies in reported outcomes. Furthermore, concerns regarding its oxalate content, bioavailability and long-term safety highlight the need for more comprehensive investigations. This review critically examines the botanical characteristics, traditional uses, phytochemical composition, pharmacological properties and underlying molecular mechanisms of Portulaca oleracea L., with particular emphasis on its potential benefits for cardiovascular and metabolic health. It also evaluates the existing experimental and clinical evidence, identifies major research gaps and discusses future perspectives to establish its therapeutic relevance and potential as a complementary approach to the management of cardiometabolic disorders.
Authors
- Anjali M. Wanegaonkar (ORCID: https://orcid.org/0000-0003-0584-1506)
- Nuzhat Ansari
- shrutika patil
- Vaishnavi Dhavan
- Sairaj Mulghe
- Bhavik Shinde
Institutions
- Lokmanya Tilak Municipal General Hospital and Lokmanya Tilak Municipal Medical College (IN)
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-21
- DOI
- https://doi.org/10.5281/zenodo.24415242
- Primary Topic
- Natural Antidiabetic Agents Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00